aod9604 fda AOD-9604 AOD9604 - Vial / 5mg
AOD9604 Vial 5mg The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant Peptide Serum AOD 9064 Peptide Serum Clinic FDA to Review Peptides Backed by RFK Jr for Compounding Pharmacies Full story & link in the comments AOD 9604 (5mg) Nordsci
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13


